ATRC logo

ATRC
Atricure Inc

390
Mkt Cap
$1.46B
Volume
508,115.00
52W High
$43.18
52W Low
$28.29
PE Ratio
-121.95
ATRC Fundamentals
Price
$29.18
Prev Close
$29.39
Open
$29.63
50D MA
$36.25
Beta
1.04
Avg. Volume
892,909.90
EPS (Annual)
-$0.2398
P/B
2.97
Rev/Employee
$395,946.67
$1,798.06
Loading...
Loading...
News
all
press releases
Citigroup Inc. Purchases 36,839 Shares of AtriCure, Inc. $ATRC
Citigroup Inc. raised its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 182.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
AtriCure, Inc. $ATRC Position Reduced by GW&K Investment Management LLC
GW&K Investment Management LLC reduced its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·5d ago
News Placeholder
Vanguard Group Inc. Sells 65,324 Shares of AtriCure, Inc. $ATRC
Vanguard Group Inc. cut its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 1.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange...
MarketBeat·7d ago
News Placeholder
AtriCure (NASDAQ:ATRC) Releases FY 2026 Earnings Guidance
AtriCure (NASDAQ:ATRC) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.090-0.150 for the period, compared to the consensus estimate of -0.030. The company also issued...
MarketBeat·7d ago
News Placeholder
Champlain Investment Partners LLC Sells 38,541 Shares of AtriCure, Inc. $ATRC
Champlain Investment Partners LLC lessened its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 1.9% during the 3rd quarter, according to its most recent Form 13F filing with the...
MarketBeat·8d ago
News Placeholder
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 37.3% in February
AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) saw a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 3,447,589 shares, an increase of...
MarketBeat·8d ago
News Placeholder
AtriCure to Participate in the Citizens Life Sciences Conference
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...
Business Wire·14d ago
News Placeholder
AtriCure (NASDAQ:ATRC) Upgraded at Wall Street Zen
Wall Street Zen upgraded AtriCure from a "buy" rating to a "strong-buy" rating in a research note on Saturday...
MarketBeat·18d ago
News Placeholder
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal
Cencora is set to merge MWI Animal Health with Covetrus in a $3.5B deal, retaining a 34.3% stake as it unlocks capital and targets animal health growth.
Zacks·19d ago
News Placeholder
Demystifying AtriCure: Insights From 6 Analyst Reviews
read more...
Benzinga·20d ago
<
1
2
...
>

Latest ATRC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.